We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
Cap. Flow
+$58.1M
Cap. Flow %
13.09%
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
7.3 quarters
Top 10 Avg Time Held Equity + Options
7.5 quarters
Top 20 Avg Time Held Equity + Options
7.9 quarters
Avg Time Held Equity only
7.4 quarters
Top 10 Avg Time Held Equity only
7.5 quarters
Top 20 Avg Time Held Equity only
7.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.51%
2 Healthcare 19.33%
3 Technology 19.31%
4 Consumer Discretionary 12.84%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VNQ icon
151
Vanguard Real Estate ETF
VNQ
$36.6B
$763K 0.17%
7,500
– –
2020 Q4
2 quarters
TWLO icon
152
Twilio
TWLO
$43.2B
$755K 0.17%
1,915
-25
-1% -$8.68K
2020 Q3
3 quarters
POL
153
DELISTED
Polished.com Inc.
POL
$755K 0.17%
+3,920
New +$1.07M
2021 Q2
0 quarters
CMCSA icon
154
Comcast
CMCSA
$74.1B
$754K 0.17%
13,215
-13,338
-50% -$746K
2016 Q4
18 quarters
IT icon
155
Gartner
IT
$12.4B
$750K 0.17%
3,096
-1,108
-26% -$242K
2016 Q4
18 quarters
IVE icon
156
iShares S&P 500 Value ETF
IVE
$49.5B
$747K 0.17%
5,062
-363
-7% -$53.5K
2020 Q4
2 quarters
AAP icon
157
Advance Auto Parts
AAP
$2.53B
$739K 0.17%
3,583
+7
+0.2% +$1.37K
2018 Q4
10 quarters
NKE icon
158
Nike
NKE
$52.5B
$738K 0.17%
4,766
+162
+4% +$21.8K
2016 Q4
18 quarters
APPH
159
DELISTED
AppHarvest, Inc. Common Stock
APPH
$738K 0.17%
46,100
-6,750
-13% -$108K
2020 Q4
2 quarters
XLV icon
160
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$726K 0.16%
5,765
-1,055
-15% -$129K
2019 Q1
9 quarters
LAB icon
161
Standard BioTools
LAB
$259M
$719K 0.16%
116,768
– –
2016 Q4
18 quarters
GVIP icon
162
Goldman Sachs Hedge Industry VIP ETF
GVIP
$579M
$715K 0.16%
7,029
-300
-4% -$29.5K
2019 Q1
9 quarters
CVS icon
163
CVS Health
CVS
$112B
$705K 0.16%
8,449
+23
+0.3% +$1.88K
2016 Q4
18 quarters
BYND icon
164
Beyond Meat
BYND
$124M
$697K 0.16%
+148
New +$590K
2021 Q2
0 quarters
VTI icon
165
Vanguard Morningstar Total Stock Market ETF
VTI
$702B
$693K 0.16%
3,108
+8
+0.3% +$1.74K
2021 Q1
1 quarter
PH icon
166
Parker-Hannifin
PH
$120B
$685K 0.15%
+2,231
New +$691K
2021 Q2
0 quarters
KO icon
167
Coca-Cola
KO
$388B
$671K 0.15%
12,297
+291
+2% +$15.8K
2021 Q1
1 quarter
BA icon
168
Boeing
BA
$147B
$655K 0.15%
2,736
-195
-7% -$47.1K
2020 Q4
2 quarters
SH icon
169
ProShares Short S&P500
SH
$973M
$654K 0.15%
10,626
– –
2019 Q1
9 quarters
CL icon
170
Colgate-Palmolive
CL
$71.7B
$653K 0.15%
8,028
+70
+0.9% +$5.72K
2021 Q1
1 quarter
MKL icon
171
Markel Group
MKL
$22.2B
$653K 0.15%
550
+2
+0.4% +$2.4K
2020 Q4
2 quarters
SCHP icon
172
Schwab US TIPS ETF
SCHP
$16.2B
$648K 0.15%
20,728
– –
2020 Q4
2 quarters
CNC icon
173
Centene
CNC
$34B
$645K 0.15%
8,842
+22
+0.2% +$1.51K
2020 Q3
3 quarters
VRTX icon
174
Vertex Pharmaceuticals
VRTX
$123B
$641K 0.14%
+3,181
New +$665K
2021 Q2
0 quarters
ISRG icon
175
Intuitive Surgical
ISRG
$149B
$640K 0.14%
2,088
+72
+4% +$20.2K
2020 Q3
3 quarters

Similar funds

Intellectus Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.

  • Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
  • Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
  • Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
  • Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
  • Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
  • Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
  • Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.

Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.